Updated Jul 16, 2026
Egholm Michael has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $15K.
Michael Egholm is the President and CEO of Standard BioTools Inc., a company focused on developing technologies for biomedical research. He has held multiple roles within the company and has been involved in its strategic direction.
| Role | Insider |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-22 | LAB | STANDARD BIOTOOLS INC. | F — Tax withholding / forfeiture | 97.6K | $1.00 | $98K |
| 2026-04-09 | LAB | STANDARD BIOTOOLS INC. | F — Tax withholding / forfeiture | 95.0K | $0.91 | $86K |
| 2026-04-09 | LAB | STANDARD BIOTOOLS INC. | M — Option exercise | 196.5K | $0.00 | |
| 2026-04-09 | LAB | STANDARD BIOTOOLS INC. | A — Grant or award | 1.04M | $0.00 | |
| 2026-02-24 | LAB | STANDARD BIOTOOLS INC. | F — Tax withholding / forfeiture | 66.1K | $1.15 | $76K |
| 2025-11-24 | LAB | STANDARD BIOTOOLS INC. | F — Tax withholding / forfeiture | 63.5K | $1.28 | $81K |
| 2025-08-20 | LAB | STANDARD BIOTOOLS INC. | F — Tax withholding / forfeiture | 54.9K | $1.27 | $70K |
| 2025-08-01 | LAB | STANDARD BIOTOOLS INC. | A — Grant or award | 3.00M | $0.00 | |
| 2025-05-28 | LAB | STANDARD BIOTOOLS INC. | F — Tax withholding / forfeiture | 9.9K | $1.09 | $11K |
| 2025-05-23 | LAB | STANDARD BIOTOOLS INC. | S — Open-market sale | 5.5K | $0.94 | $5K |
| 2025-05-22 | LAB | STANDARD BIOTOOLS INC. | S — Open-market sale | 5.1K | $1.00 | $5K |
| 2025-05-20 | LAB | STANDARD BIOTOOLS INC. | S — Open-market sale | 4.7K | $1.03 | $5K |
| 2025-05-20 | LAB | STANDARD BIOTOOLS INC. | F — Tax withholding / forfeiture | 18.3K | $1.05 | $19K |
| 2025-04-04 | LAB | STANDARD BIOTOOLS INC. | F — Tax withholding / forfeiture | 57.7K | $1.07 | $62K |
| 2025-04-04 | LAB | STANDARD BIOTOOLS INC. | M — Option exercise | 196.5K | $0.00 | |
| 2024-11-21 | LAB | STANDARD BIOTOOLS INC. | F — Tax withholding / forfeiture | 28.8K | $1.51 | $43K |
Michael Egholm is the President and CEO of Standard BioTools Inc., a company focused on developing technologies for biomedical research. He has held multiple roles within the company and has been involved in its strategic direction.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 3 open-market sales ($15K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Egholm Michael profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.